Frankel Group’s Portfolio Optimization approach utilizes a proprietary set of models and a data-driven, collaborative process. Frankel Group team conducts its own research and facilitates client interaction through a series of workshops in support of the development of multi-asset, multi-indication strategies. The process and tools provide a consistent framework with which to rank available assets, identify value creation levers, and communicate an implementation plan. The result is often a reprioritized development portfolio or a refocused commercialization effort, but all have in common the creation of new value from existing assets.
Our products include:
- Target Product Profile (TPP) development
- Indication sequencing
- Clinical development planning
- Gap analysis
- Portfolio prioritization
- Life cycle management planning
- Forecast and valuation modeling
- Franchise strategy development
